Michael D.  Dale net worth and biography

Michael Dale Biography and Net Worth

Michael Dale is Senior Vice President of the Structural Heart division at Abbott. In this role, he leads the vision and strategy for the business, which is dedicated to the design and provision of device and management solutions for the treatment of structural heart disease.

As an accomplished medical device executive, Mr. Dale has over 30 years of experience leading transformative, high-technology medical device companies in the cardiovascular, neuromodulation, diabetes, and electrophysiology markets. His past executive leadership roles span both public and private medical device companies, including GI Dynamics, Helical Solutions, ATS Medical, Endocardial Solutions, Cyberonics, St. Jude Medical, and Edwards Life Sciences. 

Mr. Dale has been an active director and served on the boards of Preceptis Medical, Enpath Medical, Rhythmia Medical, NeoChord, the Advanced Medical Technology Association (AdvaMed), and St. Mary’s University Council of Regents for the School of Graduate and Professional Programs. At present, he serves on the advisory board of Purdue University’s Weldon School of Biomedical Engineering and California Polytechnic State University’s Center for Innovation & Entrepreneurship as Student Mentor.

Mr. Dale holds a Bachelor of Science degree from California Polytechnic State University in San Luis Obispo, California.

What is Michael D. Dale's net worth?

The estimated net worth of Michael D. Dale is at least $2.77 million as of February 19th, 2020. Mr. Dale owns 24,343 shares of Abbott Laboratories stock worth more than $2,766,339 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Dale may own. Learn More about Michael D. Dale's net worth.

How do I contact Michael D. Dale?

The corporate mailing address for Mr. Dale and other Abbott Laboratories executives is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. Abbott Laboratories can also be reached via phone at (224) 667-6100. Learn More on Michael D. Dale's contact information.

Has Michael D. Dale been buying or selling shares of Abbott Laboratories?

Michael D. Dale has not been actively trading shares of Abbott Laboratories during the past quarter. Most recently, Michael D. Dale sold 4,000 shares of the business's stock in a transaction on Tuesday, March 8th. The shares were sold at an average price of $117.00, for a transaction totalling $468,000.00. Learn More on Michael D. Dale's trading history.

Who are Abbott Laboratories' active insiders?

Abbott Laboratories' insider roster includes Hubert Allen (Insider), Roxanne Austin (Director), Roger Bird (SVP), Brian Blaser (Insider), Philip Boudreau (VP), Sharon Bracken (Insider), John Capek (EVP), Jaime Contreras (SVP), Michael Dale (SVP), Lisa Earnhardt (EVP), Robert Ford (Chairman), Robert Ford (CEO), Robert Funck (CFO), Stephen Fussell (EVP), John Ginascol (EVP), Sammy Karam (SVP), Michelle Kumbier (Director), Andrew Lane (EVP), Joseph Manning (SVP), Nancy Mckinstry (Director), Mary Moreland (EVP), Louis Morrone (SVP), Phebe Novakovic (Director), Michael Pederson (SVP), Daniel Salvadori (EVP), Christopher Scoggins (SVP), Daniel Starks (Director), Julie Tyler (SVP), Andrea Wainer (EVP), Jared Watkin (SVP), Miles White (Chairman), Randel Woodgrift (SVP), and Brian Yoor (CFO). Learn More on Abbott Laboratories' active insiders.

Are insiders buying or selling shares of Abbott Laboratories?

During the last year, insiders at the healthcare product maker sold shares 10 times. They sold a total of 240,061 shares worth more than $26,014,576.06. The most recent insider tranaction occured on March, 1st when EVP Daniel Gesua Sive Salvadori sold 963 shares worth more than $114,115.50. Insiders at Abbott Laboratories own 1.1% of the company. Learn More about insider trades at Abbott Laboratories.

Information on this page was last updated on 3/1/2024.

Michael D. Dale Insider Trading History at Abbott Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2022Sell4,000$117.00$468,000.00View SEC Filing Icon  
7/28/2021Sell17,600$120.33$2,117,808.00View SEC Filing Icon  
2/19/2020Sell396$88.97$35,232.1224,343View SEC Filing Icon  
See Full Table

Michael D. Dale Buying and Selling Activity at Abbott Laboratories

This chart shows Michael D Dale's buying and selling at Abbott Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Abbott Laboratories Company Overview

Abbott Laboratories logo
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Read More

Today's Range

Now: $113.64
Low: $112.94
High: $114.01

50 Day Range

MA: $115.13
Low: $110.01
High: $120.98

2 Week Range

Now: $113.64
Low: $89.67
High: $121.64

Volume

5,278,016 shs

Average Volume

5,747,185 shs

Market Capitalization

$197.19 billion

P/E Ratio

34.86

Dividend Yield

1.97%

Beta

0.75